Back to Search
MASOUD AZODI, MD
MD
Gynecologic Oncology Physician
NPI: 1386632206IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gynecologic Oncology PhysicianPrimary
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
034999(CT)
CMS Specialties
PrimaryGYNECOLOGICAL ONCOLOGY
Education
WRIGHT STATE UNIVERSITY BOONSHOFT SCHOOL OF MEDICINE
Class of 1992
Research & Publications (20)
Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
PMID 19574774·Int J Gynecol Cancer·2009
4-observational
Brain metastases in epithelial ovarian and primary peritoneal carcinoma.
PMID 19574773·Int J Gynecol Cancer·2009
8-other
Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer.
PMID 19536090·Br J Cancer·2009
8-other
Ovarian preservation and staging in reproductive-age endometrial cancer patients.
PMID 19410280·Gynecol Oncol·2009
8-other
Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.
PMID 19386711·J Virol·2009
8-other
Peritoneal tuberculosis with elevated serum Ca-125 level mimicking advanced stage ovarian cancer: a case report.
PMID 19184073·Arch Gynecol Obstet·2009
5-case
Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor.
PMID 19177198·Neoplasia·2009
7-preclinical
Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
PMID 19117353·Cancer·2009
4-observational
Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
PMID 18976739·Am J Obstet Gynecol·2009
8-other
Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease.
PMID 17239941·Gynecol Oncol·2007
8-other
MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer.
PMID 17940625·Yale J Biol Med·2006
8-other
Atypical presentations of carboplatin hypersensitivity reactions: characterization and management in patients with gynecologic malignancies.
PMID 16647749·Gynecol Oncol·2006
8-other
Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.
PMID 16005947·Gynecol Oncol·2005
8-other
Weekly topotecan in heavily pretreated patients with recurrent epithelial ovarian carcinoma.
PMID 15992916·Gynecol Oncol·2005
8-other
Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3' untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: possible role in CSF-1 posttranscriptional regulation and tumor phenotype.
PMID 15867372·Cancer Res·2005
8-other
Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.
PMID 15581948·Gynecol Oncol·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 HOWARD AVE, YALE PHYSICIANS BUILDING
NEW HAVEN, CT 06519 - Phone
- (203) 785-4176
Quick Facts
- NPI
- 1386632206
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile